A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey

Basit Öğe Kaydı
dc.contributor.authorYilmaz, Dilek
dc.contributor.authorUstundag, Gulnihan
dc.contributor.authorBuyukcam, Ayse
dc.contributor.authorSali, Enes
dc.contributor.authorCelik, Umit
dc.contributor.authorAvcu, Gulhadiye
dc.contributor.authorBelet, Nursen
dc.date.accessioned2024-02-23T13:43:50Z
dc.date.available2024-02-23T13:43:50Z
dc.date.issued2023
dc.departmentNEÜen_US
dc.description.abstractThis multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs.en_US
dc.identifier.doi10.1007/s00431-023-04982-6
dc.identifier.endpage3242en_US
dc.identifier.issn0340-6199
dc.identifier.issn1432-1076
dc.identifier.issue7en_US
dc.identifier.pmid37140703en_US
dc.identifier.scopus2-s2.0-85158069829en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage3231en_US
dc.identifier.urihttps://doi.org/10.1007/s00431-023-04982-6
dc.identifier.urihttps://hdl.handle.net/20.500.12452/10944
dc.identifier.volume182en_US
dc.identifier.wosWOS:000992426800004en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal Of Pediatricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChildrenen_US
dc.subjectClinical Presentationen_US
dc.subjectCovid-19en_US
dc.subjectMulti-Center Studyen_US
dc.subjectPoint Prevalence Studyen_US
dc.titleA snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu